Thus, although we see no role for SMC-MR, without more rigorous lineage tracing of SMCs, such as that described by Shankman et al. (28), we cannot definitively rule out the possibility that SMC-MR plays a role in pathogenic SMC phenotype switching in atherosclerosis. This evidence concerns the gene NR3C2 and atherosclerosis.